Issued Patents 2021
Showing 1–14 of 14 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11173162 | Bicyclic heterocycles as FGFR4 inhibitors | Alexander Sokolsky, Wenqing Yao | 2021-11-16 |
| 11168089 | Fused pyrimidine derivatives as A2A / A2B inhibitors | Xiaozhao Wang, Heeoon Han, Matthew S. McCammant, Wenqing Yao, Zhiyong Yu +1 more | 2021-11-09 |
| 11161850 | Fused pyrazine derivatives as A2A / A2B inhibitors | Xiaozhao Wang, Yong Li, Chao Qi, Wenqing Yao, Wenyu Zhu | 2021-11-02 |
| 11155532 | Cyclopropylamines as LSD1 inhibitors | Wenqing Yao | 2021-10-26 |
| 11124511 | Heterocyclic compounds as immunomodulators | Jingwei Li, Wenqing Yao | 2021-09-21 |
| 11111247 | Pyrazolopyrimidine compounds and uses thereof | Oleg Vechorkin, Minh Ngoc Nguyen, Chao Qi, Anlai Wang, Wenqing Yao +1 more | 2021-09-07 |
| 11066404 | Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors | Alexander Sokolsky, Wenqing Yao | 2021-07-20 |
| 11053246 | Substituted tricyclic compounds as FGFR inhibitors | Colin Zhang, Chunhong He, Liang Lu, Wenqing Yao | 2021-07-06 |
| 11014923 | Bicyclic heterocycles as FGFR4 inhibitors | Liang Lu, Ding-Quan Qian, Wenqing Yao | 2021-05-25 |
| 11008344 | Tricyclic heteroaryl compounds as STING activators | Yingda Ye, Wenqing Yao | 2021-05-18 |
| 10968221 | Substituted [1,2,4]triazolo[1,5-a]pyrazines as LSD1 inhibitors | Xiaozhao Wang, Wenqing Yao, Colin Zhang | 2021-04-06 |
| 10947230 | Bicyclic heterocycles as FGFR inhibitors | Yaping Sun, Wenqing Yao, Meizhong Xu, Ding-Quan Qian, Fenglei Zhang | 2021-03-16 |
| 10947227 | Tricyclic heterocyclic compounds as sting activators | Neil Lajkiewicz, Yingda Ye, Zhenwu Li, Wenqing Yao | 2021-03-16 |
| 10906920 | Heterocyclic compounds as immunomodulators | Kaijiong Xiao, Wenqing Yao | 2021-02-02 |